Cointime

Celldom, Inc

company

About

Find and study cells that make diseases incurable

  • 1 - 10

Highlights

Total Funding Amount
$1.72M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.50M
Industries
Biotechnology,Genetics,Health Care,Life Science
Founded date
Feb 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

Celldom is developing next generation, high throughput single cell analysis technology to advance research, drug discovery, and drug development by illuminating diversity in cell populations. The company’s TrapTx Analyzer System uniquely integrates both phenotypic and genomic data at massive scale (up to tens of thousands of cells per experiment) to identify and characterize rare cells that play critical roles in biological pathways and disease. Celldom is developing initial applications of the platform in the areas of oncology, immunology and stem cell biology.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.72M
Celldom, Inc has raised a total of $1.72M in funding over 2 rounds. Their latest funding was raised on Sep 1, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 1, 2018 Grant $1.50M 1 — — Detail
Jan 1, 2017 Grant $225K 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Celldom, Inc is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health — Grant
Cointime
Содержание
компания